| http://www.w3.org/ns/prov#value | - An ideal cell source has not been described for bone and cartilage tissue engineering, with clinical translation limited by problems such as donor site morbidity inherent in harvest of such cell sources as end-organ cells and MSCs; as well as unpredictable quality of tissue formed in the cell-scaffold construct.
|
